Holen Sie sich die Stockscreener-App
134.09
0.16%
-0.21
Schlusskurs vom Vortag:
$134.30
Offen:
$134.25
24-Stunden-Volumen:
1.74M
Relative Volume:
0.72
Marktkapitalisierung:
$10.14B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-274.62M
KGV:
-30.98
EPS:
-4.3278
Netto-Cashflow:
$-235.37M
1W Leistung:
-0.14%
1M Leistung:
+1.02%
6M Leistung:
+104.69%
1J Leistung:
+250.47%
1-Tages-Spanne:
$134.05
$134.35
1-Wochen-Bereich:
$134.05
$134.46
52-Wochen-Spanne:
$34.34
$134.46
Apogee Therapeutics Inc Stock (APGE) Company Profile
Firmenname
Apogee Therapeutics Inc
Sektor
Branche
Telefon
650-394-5230
Adresse
221 CRESCENT ST., WALTHAM
Compare APGE vs VRTX, REGN, ARGX, RVMD, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APGE
Apogee Therapeutics Inc
|
134.09 | 10.16B | 0 | -274.62M | -235.37M | -4.3278 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Apogee Therapeutics Inc Stock (APGE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-18 | Eingeleitet | Truist | Hold |
| 2026-01-22 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-07 | Eingeleitet | Wolfe Research | Peer Perform |
| 2025-12-17 | Eingeleitet | Stephens | Overweight |
| 2025-12-10 | Eingeleitet | Deutsche Bank | Buy |
| 2025-11-03 | Eingeleitet | Craig Hallum | Buy |
| 2025-10-21 | Eingeleitet | Mizuho | Outperform |
| 2025-09-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-07-07 | Bestätigt | BTIG Research | Buy |
| 2025-03-13 | Eingeleitet | Citigroup | Buy |
| 2024-11-25 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-05-10 | Eingeleitet | BofA Securities | Buy |
| 2023-12-20 | Eingeleitet | BTIG Research | Buy |
| 2023-08-08 | Eingeleitet | Guggenheim | Buy |
| 2023-08-08 | Eingeleitet | Jefferies | Buy |
| 2023-08-08 | Eingeleitet | Stifel | Buy |
| 2023-08-08 | Eingeleitet | TD Cowen | Outperform |
| 2023-08-08 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Apogee Therapeutics Inc Aktie (APGE) Neueste Nachrichten
Is Apogee Therapeutics Inc. (APGE) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
APGE|Apogee Therapeutics Inc|Price:134.310|Chg%:+0.030 - TradingKey
Apogee Therapeutics Inc (APGE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Apogee Therapeutics Inc (APGE) Valuation: PE, PB & Fair Value Analysis - TradingKey
Apogee Therapeutics Inc (APGE) Institutional Confidence - TradingKey
TradingKey - TradingKey
Apogee Therapeutics Inc (APGE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Apogee Therapeutics Inc (APGE) Income Statement - TradingKey
Apogee Therapeutics Inc (APGE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Apogee Therapeutics Inc (APGE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
APGE|Apogee Therapeutics Inc|Price:134.310| - TradingKey
Why Wall Street Can't Get Enough of This Dividend King - The Motley Fool
Apogee Therapeutics Inc (APGE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Form 4 Apogee Therapeutics Inc For: 24 July By Investing.com - Investing.com South Africa
Apogee Therapeutics (APGE) CFO makes bona fide gift of 15,000 shares - Stock Titan
Understanding Momentum Shifts in (APGE) - Stock Traders Daily
Apogee Therapeutics stock hits all-time high at 134.34 USD By Investing.com - Investing.com South Africa
Apogee Therapeutics stock hits all-time high at 134.34 USD - Investing.com
How Will AbbVie's $10.9 Billion Acquisition of Apogee Impact Its Dividend? - Yahoo Finance
Apogee Therapeutics (APGE) Proxy filing Summary - Quartr
Form 4 Apogee Therapeutics Inc For: 16 July By Investing.com - Investing.com South Africa
Apogee Therapeutics (APGE) CMO donates 8,000 shares to donor advised fund - Stock Titan
MSN Money - MSN
FMR LLC Significantly Reduces Stake in Apogee Therapeutics Inc. - GuruFocus
Apogee Therapeutics stock hits all-time high at 133.88 USD By Investing.com - Investing.com South Africa
AbbVie, Apogee Therapeutics filed HSR July 6, setting up Aug. 5 expiration - MLex
Apogee Therapeutics (NASDAQ: APGE) backs AbbVie’s $135.11‑per‑share all‑cash deal - Stock Titan
Apogee Therapeutics stock hits all-time high at 133.88 USD - Investing.com
What This Apogee Insider Move Might Mean After a 247% Stock Run - The Motley Fool
Apogee Therapeutics CEO Michael Henderson sells $2.67m in stock By Investing.com - Investing.com India
Form 4 Apogee Therapeutics Inc For: 10 July By Investing.com - Investing.com Australia
CEO Michael Henderson Sells 20,000 Shares of Apogee Therapeutics Inc (APGE) - GuruFocus
Apogee Therapeutics CEO Michael Henderson sells $2.67m in stock - Investing.com
Apogee Therapeutics (APGE) CEO logs stock sale and 75,046-share charitable gift - Stock Titan
Apogee Therapeutics (APGE) Jumps Into Focus, Is The Stock Fully Valued? - Yahoo Finance
Blackstone pledges $1.3 billion to help develop Apogee skin drug - MSN
AbbVie files $10.9bn Apogee deal in Germany - MLex
AbbVie to buy Apogee Therapeutics for $10.9 billion in cash - MSN
Wellington-affiliates report 564,326 APGE shares (APGE) ownership update - Stock Titan
T. Rowe Price boosts Apogee Therapeutics holding to 772,969 shares (NASDAQ: APGE) - Stock Titan
FMR LLC reports 2.49M Apogee Therapeutics shares (NASDAQ: APGE) - Stock Titan
Enterprise value to EBIT forward of Apogee Therapeutics, Inc. – NASDAQ:APGE - TradingView
Price to earnings forward of Apogee Therapeutics, Inc. – NASDAQ:APGE - TradingView
My Takeaway On Apogee Therapeutics' Massive Cash Raise Humberto Cruz (GVA0ZiS739) - Mshale
Price to earnings forward of Apogee Therapeutics, Inc. – BOATS:APGE - TradingView
Apogee Therapeutics: My Take On Their Promising Eczema Drug Data Kb5089549 (eYX66guJPl) - Mshale
Enterprise value to EBITDA forward of Apogee Therapeutics, Inc. – NASDAQ:APGE - TradingView
Price to book forward of Apogee Therapeutics, Inc. – NASDAQ:APGE - TradingView
Apogee Therapeutics: AbbVie Acquisition And Merger Arbitrage Analysis APGE $APGE #APGE #stockmarket Diana Shnaider (BwfgwfruEs) - Mshale
Apogee Therapeutics | SCHEDULE 13G/A: Others - Moomoo
Apogee Therapeutics CMO Carl Dambkowski sells $730,070 in stock By Investing.com - Investing.com Australia
Finanzdaten der Apogee Therapeutics Inc-Aktie (APGE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Apogee Therapeutics Inc-Aktie (APGE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Dambkowski Carl | Chief Medical Officer |
Jul 01 '26 |
Option Exercise |
22.86 |
4,125 |
94,298 |
183,373 |
| Dambkowski Carl | Chief Medical Officer |
Jul 01 '26 |
Sale |
132.74 |
5,500 |
730,070 |
177,873 |
2.44%
0.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):